---
title: 'Software Daily Summary: What Happened on November 18, 2026'
headline: Antibiotic-resistance AI needs better data and tougher tests
description: NF-core set migration rules for typed Nextflow modules as an Infinitus
  executive described where AI agents could fit in pharma and health care.
url: https://thebench.bio/news/software/2026-11-18
topic: software
date: '2026-11-18'
covers:
- '2026-11-18'
date_published: '2026-11-18T12:04:03Z'
date_modified: '2026-11-18T12:04:03Z'
tags:
- Software
- Industry
sources: 6
publisher: TheBench.Bio
---

# Software Daily Summary: What Happened on November 18, 2026

**Antibiotic-resistance AI needs better data and tougher tests**

NF-core set migration rules for typed Nextflow modules as an Infinitus executive described where AI agents could fit in pharma and health care.

## Today in brief

A 2024 comparison found that ResFinder performed better against machine-learning models when test bacteria were less related to the training strains. [1] Jonathan L. Jacobs argues for authenticated strains, paired genome and susceptibility data, and shared benchmarks for resistance-prediction tools. [1]

NF-core published guidance for moving Nextflow modules to typed inputs and outputs, with minimum software versions tied to fixes in process caching. [2] Infinitus CEO Ankit Jain said AI agents could take on routine health-care work, while people handle unusual cases and deeper investigations. [3]

## Antibiotic-resistance AI needs reliable isolates and shared benchmarks

A 2024 comparison of four machine-learning models and ResFinder across 78 species-antibiotic datasets found that test-set design affected which approach performed better. [1] When test strains were less related to training strains, ResFinder outperformed the machine-learning models on 44% to 50% of datasets, versus 25% with random splits. [1]

Jonathan L. Jacobs, ATCC’s bioinformatics director, argues that resistance models need high-quality lab results alongside genome sequences. [1] He recommends authenticated bacterial strains with genome sequences and minimum inhibitory concentration (MIC) results from the same isolate. [1]

MIC measurements retain more detail than susceptible-or-resistant labels, which can become outdated when clinical breakpoints change, Jacobs writes. [1] A 2020 report identified more than two million contaminated GenBank records, which could expose models to DNA assigned to the wrong organism. [1]

Jacobs calls for shared test sets with fixed data splits, updated to include recent clinical isolates and historical strains. [1] ATCC researchers observed resistance genes accumulating over time when they compared historical and recent Acinetobacter baumannii isolates. [1]

## NF-core sets migration rules for typed Nextflow modules

NF-core published guidance for updating modules to use Nextflow’s static typing and record types, described as mostly stable since version 26.04.0. [2] The guidance calls for each module to accept and return one structured record, replacing the earlier allowance for multiple inputs and outputs. [2]

The guidance recommends Nextflow 26.10.4 or later for typed functions that return records, after that release fixed inconsistent record hashes that blocked process resumption. [2] For modules that stage scripts, it recommends version 26.10.6 or later, which fixed staged files being left out of process hashes. [2]

The updated structure puts staged inputs and scripts in a process stage block and moves version information into a record in the topic block. [2] It also removes ext.when from statically typed modules, leaving workflow developers to manage conditional logic. [2]

## Infinitus CEO sees agents taking on routine pharma work

Infinitus CEO Ankit Jain said agents could handle routine health-care work, with people stepping in for unusual cases, deeper investigations, or regulatory needs. [3]

Jain said agents should help field teams and physicians get information and communicate, rather than resemble automated phone systems that frustrate users. [3]

## Also worth knowing

- A November 17 survey found gaps in pharmaceutical companies’ internal AI oversight and uncertainty about who is accountable for AI systems. [4]
- A November 17 perspective argued that biopharma companies should fund tools to measure biological features current assays miss, because more data from existing assays may leave their blind spots intact. [5]
- A November 18 commentary argued that AI can help drug researchers ask deeper questions, not just supply answers. [6]

## The day in numbers

- **44% to 50%**: Share of datasets where ResFinder beat machine-learning models when test strains were less related to training strains [1]
- **26.10.4**: Minimum recommended Nextflow version for typed functions returning records [2]
- **26.10.6**: Minimum recommended Nextflow version when typed modules stage scripts [2]

## Also published

- [How Pharma Workflows Are Impacted by Agentic Models Beyond Productivity Gains](<https://www.pharmexec.com/view/workflows-impacted-agentic-models-beyond-productivity-gains>), Pharmaceutical Executive

## Sources

1. [New antibiotics need AI that gets resistance right](<https://www.drugdiscoverytrends.com/new-antibiotics-need-ai-that-gets-resistance-right/>), Drug Discovery and Development, 2026-11-18
2. [Bringing Nextflow Types and Records to nf-core/modules](<https://nf-co.re/blog/2026/types-and-records/>), nf-core, 2026-11-18
3. [The Workload Balance in Pharma Between Humans and Agentic Models](<https://www.pharmexec.com/view/workload-balance-between-humans-agentic-models>), Pharmaceutical Executive, 2026-11-18
4. [Pharma’s embraced AI. Who’s keeping it in check?](<https://www.pharmavoice.com/news/pharma-ai-governance-oversight-accountability/874826/>), PharmaVoice, 2026-11-17
5. [Biopharmas should invest in tools to close biological AI’s data gaps — a Perspective](<https://www.biocentury.com/article/661437/biopharmas-should-invest-in-tools-to-close-biological-ai-s-data-gaps-a-perspective?utm_source=bc_rss&utm_medium=rss>), BioCentury, 2026-11-17
6. [AI can give drug hunters more answers. The real advantage is asking deeper questions.](<https://pharmaphorum.com/rd/ai-can-give-drug-hunters-more-answers-real-advantage-asking-deeper-questions>), pharmaphorum, 2026-11-18

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.drugdiscoverytrends.com/new-antibiotics-need-ai-that-gets-resistance-right/>
[2]: <https://nf-co.re/blog/2026/types-and-records/>
[3]: <https://www.pharmexec.com/view/workload-balance-between-humans-agentic-models>
[4]: <https://www.pharmavoice.com/news/pharma-ai-governance-oversight-accountability/874826/>
[5]: <https://www.biocentury.com/article/661437/biopharmas-should-invest-in-tools-to-close-biological-ai-s-data-gaps-a-perspective?utm_source=bc_rss&utm_medium=rss>
[6]: <https://pharmaphorum.com/rd/ai-can-give-drug-hunters-more-answers-real-advantage-asking-deeper-questions>
